Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called higher; US job growth expected to slow

Fri, 04th Nov 2022 07:49

(Alliance News) - Stock prices in London were called higher on Friday in the wake of US Federal Reserve and Bank of England rate hikes, as markets now await a key US jobs report, expected to show a softening in the labour market.

The BoE lifted the bank rate by 75 basis points, matching the Federal Reserve's hike of US rates on Wednesday. However, Governor Andrew Bailey's dovish remarks in the subsequent press conference lay in stark contrast with the hawkishness of US counterpart Jerome Powell, putting pressure on sterling.

Bailey said UK interest rates will have to go up by "less than currently priced into financial markets". The benchmark rate currently stands at a 14-year high of 3.00%.

"Investors got the policy pivot they were looking for this week; unfortunately, not from the Federal Reserve, but from the Bank of England instead," said Swissquote Bank's Ipek Ozkardeskaya.

The BoE warned of a "very challenging outlook" for the UK economy. It expects UK gross domestic product to have contracted by 0.5% in the third quarter, before falling by 0.3% in the fourth.

The bank expects the UK economy to remain in recession throughout next year and into the first half of 2024. It only predicts a "gradual recovery" in GDP thereafter.

Focus now shifts to US nonfarm payrolls report coming out Friday afternoon London time. The US labour market is expected to have added 200,000 jobs last month, according to consensus cited by FXStreet. That outcome would be a slowdown from 263,000 in September.

The Federal Reserve will be looking for signs of a softening in the US jobs market before easing off from monetary tightening.

"A stronger than expected jobs, or wages data could only further boost the Fed hawks, whereas today's jobs figures should be particularly soft to throw cold water on very hot hawkish Fed expectations before the weekly closing bell," Swissquote Bank's Ozkardeskaya said.

"As long as the US economy remains resilient, the Fed will continue exporting its pain and inflation to the rest of the world through a too-strong US dollar. So, Americans would excuse the rest of the world for praying to see ugly jobs figures from the US, today."

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called up 46.8 points, 0.7%, at 7,235.43

----------

Hang Seng: up 5.9% at 16,237.09

Nikkei 225: closed down 1.7% at 27,199.74

S&P/ASX 200: closed up 0.5% at 6,892.50

----------

DJIA: closed down 146.51 points, or 0.5%, at 32,001.25

S&P 500: closed down 1.1% at 3,719.89

Nasdaq Composite: closed down 1.7% at 10,342.94

----------

EUR: higher at USD0.9781 (USD0.9754)

GBP: higher at USD1.1222 (USD1.1184)

USD: lower at JPY147.97 (JPY148.24)

GOLD: higher at USD1,647.31 per ounce (USD1,625.97)

OIL (Brent): higher at USD96.77 a barrel (USD95.21)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

1000 CET EU services PMI

1100 CET EU producer price index

1130 EET EU ECB President Christine Lagarde lecture at Eesti Pank

0800 CET Germany manufacturing orders and turnover

0955 CET Germany services PMI

0930 GMT UK construction PMI

0830 EDT US nonfarm payrolls

1100 EDT US services PMI

----------

Activity and jobs within Japan's service sector grew at a faster pace in October than the month before, after the Tokyo government removed all remaining Covid-related travel restrictions, according to survey results. The au Jibun Bank services purchasing managers' index rose to 53.2 points in October from 52.2 in September. The final October reading was above the neutral 50-point mark and slightly above the flash score of 53.0. The reading signals the second month in a row of expansion in Japan's service sector. S&P Global, which compiles the index, said service providers cited the recent easing in international border restrictions and the launching of the Nationwide Travel Discount Programme for the improvement in activity. Less positively, they reported a near-record pace of input cost inflation, which they passed onto their own customers. The composite PMI improved to 51.8 points in October from 51.0 in September.

----------

UK Chancellor Jeremy Hunt is looking at raising taxes on the sale of assets such as shares and property as he weighs up "difficult decisions" to address a GBP50 billion black hole in the public finances. He is also considering an increase in dividend tax, in a move that would come as a blow to entrepreneurs. A source close to Hunt confirmed the tax hikes were under consideration, but said no decisions had yet been taken – stressing "we are two weeks away" from the highly-anticipated autumn budget. It comes as the country has been struck by more bleak economic news, with the Bank of England hiking interest rates for the eighth time in a row and the UK heading into what could prove the longest recession in at least a century.

----------

Grain shipments from Ukraine resumed after Russia quickly returned to a deal allowing their safe passage following international pressure as the G7 club of rich nations vowed not to let Russia inflict "starvation" on Ukrainians. But Moscow said it had yet to decide whether to extend the grain deal beyond November 19 – the renewal date written into the original agreement brokered by the UN and Turkey to stave off a global food emergency. Moscow also accused Britain of training Ukrainian forces in "sabotage operations" and helping them carry out a weekend attack on Russia's Black Sea fleet that prompted its withdrawal from the grain agreement.

----------

BROKER RATING CHANGES

----------

Liberum cuts British Land to 'hold' ('buy') - target 355 (510) pence

----------

Morgan Stanley raises United Utilities to 'equal-weight' (underweight)

----------

Numis cuts Polar Capital to 'hold'

----------

COMPANIES - FTSE 100

----------

AstraZeneca, alongside France's Sanofi, said its respiratory syncytial virus antibody, Beyfortus, or nirsevimab, has received EU approval for use in newborns and infants. This makes the European Commission the first regulatory body to grant approval to Beyfortus. The approval was based on results from the antibody's clinical development programme, including the Melody phase III trial. It follows a recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use in September.

----------

COMPANIES - FTSE 250

----------

Apax Global Alpha said its portfolio proved "resilient" in the three months to September 30, with a total net asset value return of 3.1%, or 1.2% in constant currency. The closed-ended investment fund which focuses on private equity investments said its adjusted NAV was EUR1.4 billion at the period end, or EUR2.86 per share. This is up from EUR2.83 at the end of June. "The underlying portfolio companies continue to demonstrate their resilience in a challenging macroeconomic environment. Private equity deal activity has reduced when compared to 2021, however, the Apax Funds continue to identify attractive investment opportunities together with exits at strong uplifts to prior carrying values," said Apax COO Ralf Gruss.

----------

Morgan Advanced Materials upgraded annual guidance after a strong year-to-date. It said sales in the nine months to September were up 11% year-on-year, on an organic constant currency basis. The advanced carbon and ceramic materials manufacturer said revenue remains "robust", but notes a "slight moderation" in growth rates in the third quarter, in light of the wider economic challenges. However, it now expects full-year organic constant currency growth to be between 7% to 9% higher than previous guidance, and expects adjusted operating profit to be "marginally above" the top end of market consensus.

----------

4imprint said trading in the year so far has gone well, and it expects annual revenue to be around USD1.1 billion. Noting "consistent productivity from [its] marketing activities, relative stability in gross margins and operational leverage over the fixed and semi-fixed elements of the cost base!, it now expects pretax profit for 2022 to be at the top end of current market consensus, and "not less than USD90 million". "Looking forward, the board remains confident in and committed to the group's strategy, positioning and prospects," the promotional merchandise firm said.

----------

OTHER COMPANIES

----------

National World late Thursday said it considering mounting a takeover bid for Daily Mirror owner Reach. National World, a newspaper industry investor and owner of JPIMedia Publishing, said it is in the "early stages of exploring a possible offer" for Reach. National World says it has not yet approached Reach's board. In response, Reach said: "The board of Reach confirms that it has not received an approach from National World. The board will issue a further statement if and when appropriate. In the meantime, Reach shareholders are strongly advised to take no action."

----------

Thor Mining said drilling returned "high grade" gold from the silicified altered contact along Kelly's Ridge, at the Ragged Range in Eastern Pilbara, Western Australia. It reports the best intercept to date of 4 metres at 12.2 grammes per tonne gold from 194 metres. "This confirms the potential of the site as indicated by historical drilling. Furthermore, with more drilling results to come, we are looking forward to gaining further understanding of the project. We anticipate more positive news to be shared with the market in due course," said Managing Director Nicole Galloway Warland.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.